Published April 26, 2018
| Version v1
Journal article
Open
Another ACVR1 purification for fragment screening and co-crystallisation
Description
A rather unsuccessful purification, but nevertheless, enough for three crystal plates to follow up compound conditions
Notes
The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada, Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA Darmstadt Germany, MSD, Novartis Pharma AG, Ontario Ministry of Economic Development and Innovation, Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome [106169/ZZ14/Z].
Files
Files
(953.5 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:9c4c796dbf4bff0bb06b55cefb97bfe2
|
953.5 kB | Download |